The future challenges of Healthcare - Roche

More documents

Recommendations

Info

We are open to innovation generated by third parties "Biotech" companies Innovation Research Development r "Pharmaceutical" companies Production Marketing + Distribution Customer benefit
Roche is actively shaping its future … by building new futures for non-core businesses Pharma Starting point 1990 ... CHF 9.7 billion other 50 % 1 % 14 % 11 % Diagnostics 25 % Vitamins & Fine Chem. Fragrances & Flavours Sales and spin-off's Kontron Medi-Physics Feeds Gynecological products RBL ABX Medi-Lab Rolic DePuy (1998) MFA Actelion Novuspharma Fragrances & Flavours; Givaudan (2000) Basilea BioXell Vitamins & Fine Chemicals (2003) RCH (2004) r
Page 1 and 2: The future challenges of Healthcare
Page 3 and 4: The key drivers of the 21 st centur
Page 5 and 6: How relevant are these drivers for
Page 7 and 8: No change from the past: There is a
Page 9 and 10: The Roche assessment The healthcare
Page 11 and 12: From „traditional Pharma“ to
Page 13: A unique Roche advantage: two high
Page 17 and 18: The unique Roche innovation cosmos
Page 19 and 20: Will Roche be marginalised geograph
Page 21: Roche ambition: to be a unique inve

The future challenges of Healthcare - Roche

Create successful ePaper yourself

Delete template?

Save as template?